Drawing for MAGNOTECH

USPTO serial 79198471

MAGNOTECH

Reviewed by CopyMark Law Group

Reg. 5314288Status 709
Filing date
Status date
Registration date
Oct 24, 2017
Examiner
SAPPENFIELD, ANN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAGNOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marie Anne Mastrovito

Marie Anne Mastrovito Womble Bond Dickinson (US) LLP950 3rd Avenue, Suite 2400New York, NY 10022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Diagnostic testing apparatus and instruments for use in non-medical immunoassay procedures, namely, handheld analyzers and testers for measuring substances such as hormones, drugs, proteins and nucleic acids in blood or saliva; non-medical testing apparatus provided in packages, namely, disposable biosensor cartridges; apparatus and instruments for carrying out non-medical diagnostic tests, namely, analyzers and testers for measuring substances such as hormones, drugs, proteins and nucleic acids in blood or saliva; computers adapted for computer-aided testing of blood and salivaSECTION 71 - CANCELLED—
010Medical apparatus containing diagnostic reagents and diagnostic chemical products for use in the analysis and testing of blood and saliva; medical diagnostic and immunodiagnostic apparatus and instruments for use in the analysis and testing of blood and saliva; automatic testing apparatus for medical use, also in packet form, namely, automatic testing apparatus for measuring substances such as hormones, drugs, proteins and nucleic acids in blood or saliva; medical apparatus and instruments in packet form for testing for the presence of analytes in biological fluids, other fluids and other matrices in the nature of disposable biosensor cartridgesSECTION 71 - CANCELLED—
042Medical, biochemical, toxicological and other analytical laboratory diagnostic testing; design and development of medical diagnostic testing apparatus and reagents; technical consultancy with regard to medical health; diagnostic testing for scientific research purposes relating to human or animal health; laboratory testing services in the field of chemistry; immunodiagnostic testing, namely, testing for the presence of drugs or other analytes in biological fluids or other matrices, for research purposes; medical researchSECTION 71 - CANCELLED—
044Medical consultancy and professional medical assistance; medical services; clinical services, namely, blood and saliva testing; medical consultancy relating to medical health; medical services for the diagnosis and treatment of the physiological condition of the human body; medical researchSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 29, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 28, 2025INPCINVALIDATION PROCESSED—
Jan 11, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 10, 2024C71TCANCELLED SECTION 71—
Oct 24, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 22, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 22, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 27, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 27, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 27, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 27, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 1, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 29, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 10, 2019CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 6, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 16, 2019RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 30, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 1, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 1, 2018FIMPFINAL DISPOSITION PROCESSED—
Jan 24, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 24, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 18, 2017GPNXNOTIFICATION PROCESSED BY IB—
Aug 8, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 8, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 19, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 6, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 21, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 21, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 21, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 21, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 21, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 28, 2017ALIEASSIGNED TO LIE—
Apr 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 17, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 8, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 25, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 25, 2017RFRRREFUSAL PROCESSED BY MPU—
Jan 24, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 23, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2017DOCKASSIGNED TO EXAMINER—
Dec 27, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 22, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2016SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance